14 Min Read
April 4 (Reuters) - Some U.S. stocks on the move on Thursday:
U.S. stocks rose on Thursday as robust action by the Bank of Japan and supportive remarks by U.S. officials indicated that equity markets would continue to be propped up, but gains were capped by data showing U.S. jobless claims unexpectedly rose.
The Dow Jones industrial average was up 52.30 points, or 0.36 percent. The Standard & Poor's 500 Index was up 5.89 points, or 0.38 percent. The Nasdaq Composite Index was up 1.59 points, or 0.05 percent.
** TOYOTA MOTOR , $105.77, up 5 pct (0934 ET)
** HONDA MOTOR CO , $39.20, up 5 pct
** SONY CORP , $16.87, up 3 pct
** SUMITOMO MITSUI FINANCIAL GROUP INC , $8.60, up 10 pct (0951 ET)
** MIZUHO FINANCIAL GROUP INC , $4.44, up 7 pct (0951 ET)
** MITSUBISHI UFJ FINANCIAL GROUP INC , $6.24, up 7.5 pct (0952 ET)
** NOMURA HOLDINGS INC , $6.27, up 7 pct (0953 ET)
The Bank of Japan shocked markets with a radical overhaul of its monetary policy, adopting a new balance sheet target and pledging to double its government bond holdings in two years.
** BEST BUY CO, $24.27, up 12 pct (1054 ET)
Samsung is planning to install its own brand shops in more than 1,400 Best Buy stores in the United States this year, a move that some on Wall Street said could help the world's largest consumer electronics chain boost traffic and sales in its stores. Best Buy was one of the top percentage gainers on the New York Stock Exchange.
** HARVEST NATURAL RESOURCES, $2.81, down 5 pct (0942 ET)
The oil and gas company said that its financial statements for 2010, 2011 and the first three quarters of 2012 should no longer be relied upon. (link.reuters.com/reb27t)
The company warned in March that some accounting errors might force it to restate results for certain periods in the past three years, raising doubts about its ability to continue as a going concern due to its liquidity position.
** COLLABRX INC, $4.36, up 37 pct (1012 ET)
Data analytics firm CollabRx Inc and Belgium-based gene sequencing company OncoDNA SA signed a multi-year deal to buy CollabRx's technology and content to be used in conjunction with OncoDNA's cancer mutation panels.
** COMBIMATRIX CORP, $4.31, up 25 pct (1017 ET)
The diagnostic test provider said it expects to report a growth of 124 percent for its prenatal tests in the quarter ended March 31. CombiMatrix is scheduled to report results in early May.
** IXIA INC, $18.66, down 8 pct (1110 ET)
The company, which makes telecom network testing products, said it would need to restate results for 2010, 2011 and the first three quarters of 2012.
The company said "it needed to correct an error related to the manner in which it recognizes revenues for its warranty and software maintenance contracts". (link.reuters.com/kug27t)
** WALTER ENERGY INC, $24.61, up 4 pct (1112 ET)
The metallurgical coal miner, squaring off with a hedge fund that wants to replace half its board, advised its shareholders to not vote for Audley Capital Advisors LLP's nominees.
The British hedge fund, which owns a minority stake in the company, said in mid-February that it planned to nominate five candidates to Walter Energy's 10-member board. The fund has criticized Walter Energy for missing forecasts and said its directors have very little mining experience.
** FACEBOOK INC, $26.46, up 1 pct (0933 ET)
The company is expected to showcase software on Thursday that places the No. 1 social network front-and-center on Android smartphones, as it looks for new ways to keep its billion users worldwide hooked on the service.
** METROPCS, $11.18, up 2 pct (1023 ET)
Deutsche Telekom said on Thursday it has no plans to amend the terms of a proposed merger of its T-Mobile USA unit with rival MetroPCS.
Asked whether the Bonn-based company was working on sweetening the deal, a spokesman said: "No, we can flatly deny that."
** FINISAR CORP, $13.39, up 6 pct (0936 ET)
Lazard Capital Markets raised its rating on the network equipment maker's stock to "buy" from "neutral", saying the company's datacom business, which accounts for 62 percent of sales, will benefit from large data center upgrade cycles at operators such as Apple, Amazon, and Google in the coming quarters.
** GREENBRIER COS INC, $20.70, down 5 pct
The railcar maker, which was riding a surge in demand for oil tank cars until the middle of last year, reported lower-than-expected quarterly revenue as overall deliveries fell for the third quarter in a row.
** PSIVIDA CORP, $2.40, up 6 pct (0933 ET)
The drugmaker said it signed a deal with a global pharmaceutical company to test two of its opthamology-related drug delivery systems -- Durasert and Tethadur. The company did not name the global partner.
** MIDSTATES PETROLEUM CO INC, $7, down 5 pct (1026 ET)
Midstates Petroleum said it will buy oil and gas acreage in the Anadarko Basin in Texas and Oklahoma from Panther Energy LLC and its partners Red Willow Mid-Continent LLC and Linn Energy Holdings LLC for $620 million in cash.
** ADDUS HOMECARE CORP, $12.57, down 4 pct (1030 ET)
Brokerage Oppenheimer downgraded the stock of the home health provider to "perform" from "outperform," saying there are few near-term positives left to drive higher earnings.
** SUNPOWER CORP, $9.16, down 5 pct (1026 ET)
Raymond James analyst Pavel Molchanov said the U.S. solar company's shares had been overbought earlier in the year and traders were now cashing in on a rise. The U.S. solar company's stock rose to a year high of $13.88 on Feb. 20.
"The market has become more risk averse in recent weeks compared to January and February...and profit taking is absolutely appropriate," Molchanov said.
** CRYOLIFE INC, $6.10, up 4 pct (0943 ET)
The medical device maker said its dialysis device was approved by the U.S. health regulator. CryoLife plans to launch the device, named HeRO or Hemodialysis Reliable Outflow, in the fourth quarter of 2013.
** ALLOT COMMUNICATIONS , $12.06, up 4 pct (1010 ET)
The company, which supplies technology that allows telecoms operators to monitor and allocate bandwidth, said it has secured a $6.5 million order from a Tier-1 mobile operator in the Europe, Middle-East and Africa region. The order is a licensing expansion of an existing contract.
** ARIAD PHARMACEUTICALS INC, $17.25, up 3 pct (0943)
The drugmaker said more than 325 patients are being treated with the company's cancer drug, Iclusig, after 12 weeks of launching it in the U.S. Ariad also anticipates a European approval of the drug in the second quarter and expects to launch the drug by July.
** MERRIMACK PHARMACEUTICALS INC, $6.09, down 2 pct (0935 ET)
The company said one of three patient groups in a mid-stage trial of its experimental lung cancer drug failed to meet the main goal of improving survival rates after four months of treatment without the disease worsening.
** PROVIDENT NEW YORK BANCORP, $9.22, up 5 pct
** STERLING BANCORP, $11.38, up 14 pct (0949 ET)
Provident New York Bancorp will buy Sterling Bancorp in a stock deal valued at $344 million to expand its presence in the New York City region, the companies said. Sterling has long been considered takeover target because of its attractive small business lending franchise.
** LATTICE SEMICONDUCTOR CORP, $5.37, up 3.2 pct (1004 ET)
Mizuho Securities raised its rating on the chipmaker's stock to "buy" from "neutral" and raised its price target on the stock to $7, citing improving demand in the communications and industrial end markets, which should accelerate in the second half of the year.
** ING GROUP , Wednesday close $7.14, up 4 percent (0958 ET)
Exane BNP Paribas raised the Dutch financial services company to "outperform" from "neutral."
** UNIVERSAL DISPLAY CORP, $28.65, up 4 pct (0936 ET)
Needham & Co upgraded the organic light-emitting diode (OLED) display technology provider's stock to "buy" from "hold," citing higher demand for Universal Display's products driven by Samsung Electronics' Galaxy S4 smartphone.
"With the ramp in Samsung's new S4, which we expect will drive demand for Universal Display's green phosphorescent material, and growth in the broader OLED market, we believe management's guidance for 45-55 percent growth in materials revenue in 2013 is reasonable," Needham analyst James Ricchiuti wrote in a note.
** PANERA BREAD CO, $174.35, up 3 pct (0937 ET)
** BRINKER INTERNATIONAL INC, $38.45, up 2 pct
Brokerage Goldman Sachs raised its ratings on both the restaurant chains' stocks, citing improving consumer sentiment and continued job or wage growth, despite headwinds from the impact of the 2 percent payroll tax hike, higher gas prices, and delayed tax refunds.
** CARNIVAL CORP, $33.07, down 2 pct (0938 ET)
Strong winds caused the damaged Carnival cruise ship Triumph to break loose on Wednesday from its moorings at a Mobile, Alabama, shipyard where it was being repaired, a company spokesman said, and it drifted into a cargo vessel.
Last month, Carnival lowered its profit forecast primarily because of lost bookings and the cost of fixing the Triumph, which was adrift in the Gulf of Mexico for five days in February with more than 4,000 passengers aboard.
** JINKOSOLAR HOLDING CO LTD, $4.25, up 5 pct (0938 ET)
The solar panel maker signed a 360 million yuan ($58 million) loan agreement with China Development Bank and said it will use the financing to develop solar power plants in China.
The company said last December that its Swiss unit will get up to $1 billion over five years from the bank.($1 = 6.2010 Chinese yuan)
** NAVIDEA BIOPHARMACEUTICALS INC, $2.69, up 5 pct (0939 ET)
The company said its cancer diagnostic agent was effective in identifying the first lymph node reached by the disease in patients with head and neck cancer, paving the way to expand its use in all solid cancers.
The company said a safety monitoring committee recommended that the trial be stopped early due to the positive results.
** RENESOLA LTD, $1.31, up 4 pct premarket (0939 ET)
The Chinese solar panel maker signed a deal with Solairedirect SA to produce 120 megawatts (MW) of solar panels in South Africa, following in the footsteps of rival JinkoSolar Holding Co Ltd.
JinkoSolar on Wednesday said it would supply 115 MW of solar panels to two projects in South Africa. The country has seen strong growth in clean energy investments as it looked to reduce carbon emissions and bolster electricity supply.
** CAPLEASE INC, $6.03, down 2 pct (0941 ET)
The real estate investment trust said late on Wednesday that it was offering 6.5 million shares of its common stock. CapLease said it intends to use the proceeds to fund real property acquisitions.
** CENTURYLINK INC, $35.98, up 2.5 pct (0941 ET)
JP Morgan upgraded the rural telecom service provider's stock to "overweight" from "neutral," saying the company's 6.2 percent dividend yield is sustainable and attractive compared to Verizon's 4.2 percent and AT&T's 4.8 percent.
Shares in CenturyLink fell sharply in February after the company said it was cutting its dividend by 25 percent and posted weaker-than-expected quarterly results.
** MITCHAM INDUSTRIES INC, $15.63, down 5 pct (0942 ET)
The seismic equipment maker reported lower-than-expected fourth-quarter results due to project delays in Canada, Russia and Latin America. The hold-up in projects means a delay in leasing Mitcham's equipment.
The company reported earnings of 26 cents per share and revenue of $28.4 million. Analysts on average expected the company to earn 40 cents per share, on revenue of $29.3 million.
** SMITH AND WESSON CORP, $8.36, down 2 pct (0944 ET)
** STURM RUGER & CO INC, $47.03, down 0.3 pct (0944 ET)
Connecticut lawmakers voted on Thursday to approve a new gun-control bill in response to last December's shooting at a school in Newtown in which 20 children and six adults were killed. The new law would require background checks for private gun sales, ban the sale of high-capacity ammunition clips of the kind used at the Newtown shooting and require current owners of those large clips to register them with the state.
** BASIC ENERGY SERVICES INC, $11.58, down 2 pct (1005 ET)
The oilfield services provider's Chief Financial Officer filed with the Securities and Exchange Commission proposing to sell 6,475 restricted shares, according to a filing made on Wednesday.
Investors typically receive restricted securities through employee stock benefit plans and an exemption from the SEC's registration requirements is required to sell them in the public marketplace.
** SEQUENOM INC, $3.99, up 3 pct (1107 ET)
Wedbush analyst Zarak Khurshid raised his rating on the diagnostic company's stock to "outperform" from "neutral," saying that the fears raised by a leaked article from the Wall Street Journal- which said the U.S. regulator would regulate new prenatal screening tests - were "overblown".
"We believe the FDA has missed its window to regulate the non-invasive prenatal testing market, thus reducing the risk of disruption," Khurshid wrote in a note to clients. (Compiled by Pallavi Ail in Bangalore,)